The oral use of low doses of interferon (IFN)-α has been shown to exhibit beneficial effects in mice or human with acquired immunodeficiency syndrome (AIDS) [1], hepatitis B [2], aphthous stomatitis [3], and measles [4]. Here, IFNA1 is linked to AIDS.